ZA997705B - Production methof of isoxazolidinedione compound. - Google Patents

Production methof of isoxazolidinedione compound.

Info

Publication number
ZA997705B
ZA997705B ZA9907705A ZA997705A ZA997705B ZA 997705 B ZA997705 B ZA 997705B ZA 9907705 A ZA9907705 A ZA 9907705A ZA 997705 A ZA997705 A ZA 997705A ZA 997705 B ZA997705 B ZA 997705B
Authority
ZA
South Africa
Prior art keywords
methof
production
isoxazolidinedione
compound
isoxazolidinedione compound
Prior art date
Application number
ZA9907705A
Other languages
English (en)
Inventor
Koji Ando
Masanobu Suzuki
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of ZA997705B publication Critical patent/ZA997705B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9907705A 1998-03-30 1999-12-15 Production methof of isoxazolidinedione compound. ZA997705B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10409898 1998-03-30

Publications (1)

Publication Number Publication Date
ZA997705B true ZA997705B (en) 2000-06-27

Family

ID=14371652

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9907705A ZA997705B (en) 1998-03-30 1999-12-15 Production methof of isoxazolidinedione compound.

Country Status (25)

Country Link
US (4) US6248897B1 (es)
EP (3) EP1384722A1 (es)
JP (1) JP2000143596A (es)
KR (1) KR100321608B1 (es)
CN (4) CN1130361C (es)
AR (1) AR015745A1 (es)
AT (1) ATE258931T1 (es)
AU (1) AU738200B2 (es)
BR (1) BR9906312A (es)
CA (1) CA2291620C (es)
CO (1) CO5080736A1 (es)
CZ (1) CZ296507B6 (es)
DE (1) DE69914557T2 (es)
ES (1) ES2211053T3 (es)
HU (1) HUP0003273A3 (es)
IL (1) IL133146A (es)
NO (4) NO314403B1 (es)
NZ (1) NZ501896A (es)
PE (1) PE20000359A1 (es)
RU (1) RU2180663C2 (es)
SG (1) SG73627A1 (es)
SK (1) SK161499A3 (es)
TW (1) TWI224594B (es)
WO (1) WO1999050267A1 (es)
ZA (1) ZA997705B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2180663C2 (ru) 1998-03-30 2002-03-20 Джапан Тобакко Инк. Способ получения изоксазолидиндионового соединения, способ получения оксазолилэтанольного соединения (варианты), способ получения аспартатного соединения, способ получения оксазолилацетатного соединения, способ получения метансульфонатного соединения, способ получения бензилиденового соединения
US6784199B2 (en) 2000-09-21 2004-08-31 Aryx Therapeutics Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
US6958355B2 (en) 2000-04-24 2005-10-25 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
JP4073786B2 (ja) * 2001-04-16 2008-04-09 田辺三菱製薬株式会社 高コンダクタンス型カルシウム感受性ｋチャネル開口薬
US6696474B2 (en) * 2002-04-03 2004-02-24 Warner Lambert Co. Llc. Antidiabetic agents
US6716842B2 (en) * 2002-04-05 2004-04-06 Warner-Lambert Company, Llc Antidiabetic agents
TWI343915B (en) * 2002-10-07 2011-06-21 Hoffmann La Roche Chirale ppar agonists
DE10328174A1 (de) * 2003-06-24 2005-01-13 Bayer Healthcare Ag Verfahren zur Herstellung von Aryloxazolylethylalkohol
BRPI0609580A2 (pt) * 2005-03-22 2010-04-20 Hoffmann La Roche composto, polimorfo cristalino, processo para a sua manufatura, composições farmacêuticas que o contêm, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com dpp-iv e utilização do composto
EP1892231A1 (en) * 2006-08-21 2008-02-27 Bayer Schering Pharma Aktiengesellschaft A large scale method for the deoxofluorination of ketones

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1859667A (en) * 1930-05-14 1932-05-24 J K Gruner Lumber Company Jointed lumber
JPS58219169A (ja) 1982-06-15 1983-12-20 Takeda Chem Ind Ltd オキサゾ−ル酢酸誘導体
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
US5059720A (en) * 1990-01-31 1991-10-22 E. I. Du Pont De Nemours And Company Hydroxy containing fluorovinyl compounds and polymers thereof
KR930701420A (ko) 1990-08-23 1993-06-11 알렌 제이. 스피겔 혈당저하제로서의 하이드록시우레아 유도체
CA2075553A1 (en) * 1992-08-07 1994-02-08 George Zafir Insulated panel
DE69322639T2 (de) * 1992-12-28 1999-07-22 I.G. Technical Research Inc., Higashine, Yamagata Feuerbeständiges wärmeisolierendes paneel
JPH07188227A (ja) 1993-12-24 1995-07-25 Japan Tobacco Inc チアゾリジン誘導体及びオキサゾール誘導体
EP0684242B1 (en) 1993-12-27 1999-05-06 Japan Tobacco Inc. Isoxazolidinedione derivative and use thereof
TW403748B (en) * 1994-11-02 2000-09-01 Takeda Chemical Industries Ltd An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same
NZ314406A (en) * 1996-03-18 2000-12-22 Sankyo Co Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
US5768850A (en) * 1997-02-04 1998-06-23 Chen; Alen Method for erecting floor boards and a board assembly using the method
RU2180663C2 (ru) * 1998-03-30 2002-03-20 Джапан Тобакко Инк. Способ получения изоксазолидиндионового соединения, способ получения оксазолилэтанольного соединения (варианты), способ получения аспартатного соединения, способ получения оксазолилацетатного соединения, способ получения метансульфонатного соединения, способ получения бензилиденового соединения
DE19851200C1 (de) * 1998-11-06 2000-03-30 Kronotex Gmbh Holz Und Kunstha Fußbodenpaneele
US8234204B2 (en) * 2000-11-13 2012-07-31 Goldman, Sachs & Co. Method and system for matching short trading positions with long trading positions

Also Published As

Publication number Publication date
CN1130361C (zh) 2003-12-10
US6444827B2 (en) 2002-09-03
ES2211053T3 (es) 2004-07-01
WO1999050267A1 (fr) 1999-10-07
NO995851L (no) 1999-11-29
BR9906312A (pt) 2000-07-11
CN1511833A (zh) 2004-07-14
NO315197B1 (no) 2003-07-28
NO20024058D0 (no) 2002-08-26
PE20000359A1 (es) 2000-05-17
HUP0003273A3 (en) 2002-02-28
CZ296507B6 (cs) 2006-03-15
EP1384722A1 (en) 2004-01-28
US6699996B2 (en) 2004-03-02
CN1495174A (zh) 2004-05-12
JP2000143596A (ja) 2000-05-23
NO20024060L (no) 1999-11-29
EP0992503A1 (en) 2000-04-12
EP0992503A4 (en) 2001-11-07
US6248897B1 (en) 2001-06-19
CA2291620C (en) 2003-10-07
HUP0003273A2 (hu) 2002-01-28
DE69914557T2 (de) 2005-01-05
CN1235887C (zh) 2006-01-11
KR20010013044A (ko) 2001-02-26
IL133146A0 (en) 2001-03-19
EP1375499A1 (en) 2004-01-02
NO315199B1 (no) 2003-07-28
DE69914557D1 (de) 2004-03-11
AU738200B2 (en) 2001-09-13
CN1232511C (zh) 2005-12-21
NO20024059L (no) 1999-11-29
NO995851D0 (no) 1999-11-29
AU2854899A (en) 1999-10-18
US20010039352A1 (en) 2001-11-08
KR100321608B1 (ko) 2002-02-02
ATE258931T1 (de) 2004-02-15
CN1272109A (zh) 2000-11-01
EP0992503B1 (en) 2004-02-04
EP1384722A8 (en) 2004-09-08
IL133146A (en) 2004-02-08
RU2180663C2 (ru) 2002-03-20
NO20024059D0 (no) 2002-08-26
SK161499A3 (en) 2000-06-12
CN1781915A (zh) 2006-06-07
CA2291620A1 (en) 1999-10-07
NO20024058L (no) 1999-11-29
CZ422499A3 (cs) 2000-04-12
NO20024060D0 (no) 2002-08-26
EP1375499A8 (en) 2004-09-08
US20020188133A1 (en) 2002-12-12
SG73627A1 (en) 2000-06-20
US20050159466A1 (en) 2005-07-21
CO5080736A1 (es) 2001-09-25
AR015745A1 (es) 2001-05-16
NZ501896A (en) 2000-11-24
NO314403B1 (no) 2003-03-17
US6995271B2 (en) 2006-02-07
NO315198B1 (no) 2003-07-28
TWI224594B (en) 2004-12-01

Similar Documents

Publication Publication Date Title
MXPA01003642A (es) Sintesis enzimatica de adnss.
AU4925799A (en) Production of propylene
HUP0100779A3 (en) Novel derivatives of 3,3-diphenylpropylamines
HK1039487A1 (en) Process for the synthesis of azetidinones.
GB0216752D0 (en) Novel compound
ZA997705B (en) Production methof of isoxazolidinedione compound.
ZA983697B (en) Production of L(+)-Lactate.
IL137518A0 (en) Derivatives of 1,2,4-oxadiazolone
ZA994085B (en) Compound liquor.
ZA992899B (en) Novel compound.
HK1027110A1 (en) Production of avermectin compounds.
ZA991514B (en) Production of polyamides.
ZA200007084B (en) Novel salts of N-tert-butylhydroxylamine.
AU3872899A (en) Formaldehyde production
AUPP132198A0 (en) Improved production of reticuline
IL124920A0 (en) Manufacture of boxes
ZA99293B (en) Production of alkyl esters.
GB9808896D0 (en) Novel compound
GB9802487D0 (en) Production of heptafluoropane
GB9815041D0 (en) Chocolate production
ZA200101421B (en) Production of propylene.
GB9908707D0 (en) Production of prepared meals
ZA992875B (en) Production of catalogues.
AU2003204625A1 (en) Improved production of reticuline
MXPA01001471A (es) Nuevo proceso para la sintesis de exoquelinas.